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Inflammatory bowel disease (IBD) is a set of disorders that involve chronic 
inflammation of digestive tracts, e.g., Crohn's disease (CD) and ulcerative colitis (UC). 
Millions of people around the world have inflammatory bowel disease. However, it is 
still difficult to treat IBD due to its unknown cause. In fact, accurately diagnosing 
inflammatory bowel disease (IBD) can be very challenging too since some of IBD 
symptoms can mimic those of other conditions. In this work, we apply classification 
methods to help improve the success rate of diagnosis. We study four formulations of 
IBD classification: i) IBD and non-IBD (binary classification), ii) CD and non-IBD 
(binary classification),  iii) UC and non-IBD (binary classification),  and iv) UC, and 
non-IBD (ternary classification). We have applied a number of classification methods, 
including decision tree, Naive Bayes, K-nearest neighbor, and rule-based classifier, to the 
two IBD classification problems using a metagenomic dataset collected from stool 
samples. Our study shows that a rule-based classifier achieves the best combination of 
classification accuracy and readability. We also explored the roles of attributes in the 
diagnosis of IBD based on interpretation of learned models. Studying the importance of 
specific attributes could lead to a better understanding of IBD by either discovering new 
connections or reinforcing known ones.
1 
Chapter 1. Introduction 
Inflammatory bowel disease (IBD) is a group of disorders that cause chronic 
inflammation of the gastrointestinal (GI) tract that causes an array of symptoms. Over 3.5 
million people are diagnosed with IBD and that number is still increasing, not only in 
North America and Europe where is it most common, but also around the world [1]. 
There are two main types of IBD with the majority of diagnoses: Crohn’s disease (CD) 
and ulcerative colitis (UC). While CD and UC are very similar, they do have specific 
difference. CD can affect anywhere along whole GI tract (from mouth to anus) with 
damaging inflammation appearing in patches and with the possibility of reaching 
multiple layers of the GI tract wall, while UC can only affect the large intestine (colon) 
and sometimes rectum, with damage continuous and inflammation is only in the 
innermost layer of the colon lining [2].  
CD and UC are very similar with their symptoms and most (but not all) treatment 
options. However, if surgery is required, the type of surgery and area operated on are 
different due to the difference in inflammation. Due to the continuous damage of UC, it is 
far easier to perform a removal surgery to remove only the parts of the colon that are 
affected. CD’s damage often cannot be simply removed because it only appears in 
scattered patches and/or it may appear in areas that cannot be removed. [3]. For this 
reason, the distinction between CD and UC in IBD diagnosis is important so that medical 
professionals and patients are aware of all options open to them. 
While IBD is not fatal (unless there are major complications), it has a large 
impact on the lives of those who have the disease, especially if remission cannot be 




fatigue, diarrhea, and bloody stools. IBD also increases chances of having many other 
diseases or disorders such as, cardiovascular disease, respiratory disease, cancer, arthritis, 
weak or failing kidneys, any liver condition, and ulcer [4]. IBD can bring additional 
challenges from the symptoms and risk factors. With the lack of public understanding of 
IBD, patients can be treated with insensitivity to their condition, either by not 
understanding the severity of their condition or not believing their condition at all. This 
can cause them to keep their condition to themselves and fail to reach out for support 
which in turn leads to stress, anxiety, depression, and/or other mental health problems. 
The stress and cost of treatment and eve bathroom access can also provide more 
challenges to patients [5]. 
The previously mentioned symptoms and possible other condition that IBD 
patients can have may lead to a misunderstanding that a patient has other disorders such 
as Irritable Bowel Syndrome, celiac disease, tuberculous enteritis, duodenal ulcer, 
appendicitis, anal fistula, enterocolitis, hemorrhoids, rectal varix, and rheumatoid arthritis 
[2] [5]. In summary, IBD can be difficult to diagnose because its cause is unknown, and it 
can be easily diagnosed as other diseases with similar appearing conditions. This can 
cause many patients to go untreated while for medical professionals determine what 
might be causing their symptoms and provide a correct diagnosis. A study performed by 
Yong Hoon Kwon and Yong Joo Kim show that the average diagnostic time lag in 
children with CD was 3.36 months, and with UC was 2.2 months but this time can 
increase by month or years with an incorrect diagnosis [5]. This can cause patients to 




they do not have which may harm them more. There are a few tests that medical 
professionals order which all have varying goals, success, and burden on the patients 
Although the exact cause of IBD is unknown, there are some known factors that 
increase the chance of someone having it and changes in gut microbiota are seen as well. 
These factors include, age, race/ethnicity, family history, smoking, and environment [6] 
[7]. The change in the gut microbiota is highly debated because it is unknown whether 
the change is the cause of the IBD or the consequence of it [8]. This debate between 
change and consequence of the gut microbiota change causes many different paths in 
treatments such as chemotherapy, complementary and alternative medicine, traditional 
Chinese herbal medicine, prebiotics, probiotics, synbiotics, and fecal microbiota 
transplantation.  Some of these tests include, general blood test, stool test, medical 
imaging, colonoscopy, and colon biopsy [9]. Despite the variety of test, the colonoscopy 
is considered to the benchmark for monitor any IBD activity because of its accuracy and 
the amount of the information that gained in comparison to the other tests. The 
colonoscopy has an 89% accuracy of diagnosis of CD or UC [10]. With the proper 
medication, many patients find remission and experience little to no symptoms. 
With the complexity of medical diagnosis and the human body, it can be quite 
difficult for humans to find the connects between the conditions of the human body and 
varies disorders. All the different conditions in the human body from DNA to heart rate 
to abundance of bacteria in a patient stool can be measured and recorded to produce large 
dataset that focus on the wellbeing of the body. With the use of machine learning 
techniques, these datasets can be processed to reveal knowledge the body that were not 




machine learning technique cannot replace the knowledge, intuition, and experience of 
medical professionals, they can be used as another tool to extend our understanding of the 
problem. Just like any other tool, there is no tool that works for all problems. This is why 
various machine learning techniques should be tested to find which one is best suited for 
a specific problem or set of problems. 
 This thesis discusses the diagnosis of IBD using classification methods while 
looking at three binary classifications (IBD and nonIBD, CD and nonIBD, UC and 
nonIBD) and ternary classification (CD, UC, and nonIBD). The models used include 
C4.5 Decision Tree, Naïve Bayes, k-Nearest Neighbor, RIPPER, and Decision Table. 
The ensemble methods of bagging and boosting are also used on the C4.5 decision tree 
and the RIPPER algorithm. The use of these classification models to diagnose IBD using 
a Metagenomic dataset collected from stool samples. Waikato Environment for 
Knowledge Analysis (WEKA) is used in the implementation of the classification models. 
The findings of this thesis show that the RIPPER algorithm has great potential for 
diagnosing IBD because of its interpretability, a higher classification accuracy than a 






Chapter 2. Literature Review 
 
The use of data mining models and machine learning techniques in the medical 
field is not a new area of research and there is research that looks directly at diagnosing 
IBD. This allows for the comparisons of results, classification models, and datasets and 
also a comparison to the current test standards. While the combination of the 
classification models and metagenomic data is what being studied in the theis, the study 
of metagenomic data from stool samples has been used to learn more about a patient’s 
microbiota and test for infection. 
 
2.1 Current IBD Testing Methods 
 Isabelle Noiseux et al. discusses the various test methods being used today and 
studied the cost, refusal rates, comfort and fear levels, knowledge, etc. that patient 
associate with the different tests in their study, “Inflammatory bowel disease patient 
perceptions of diagnostic and monitoring tests and procedures” [9]. They collected survey 
data through the Crohn’s and Colitis Canada association about the five common tests 
used to test for IBD: general blood test, stool test, colonoscopy, colon biopsy and medical 
imaging. The survey received 210 responds where 145 had CD and the other 65 had UC.  
The study first looked at what tests were requested the most and were refused the most 
with both being the general blood test even when it provides the least information. They 
continued by investigating why patients refuse specific tests. The study continues by 
looking at patients’ comfort, understanding of the tests, and what information about the 
test was provided by the medical professional. This information can be used to help 




patients, and understand how patients view the tests. Patients appeared to be most 
comfortable with the stool sample and medical professionals need to provide more 
information about risks of having false positive or negative tests. 
 
2.2 Data Mining and Medicine 
Elahe Parva et al. discusses the emerges of data mining in the medical field, 
especially in emergency medicine in their paper, “The Necessity of Data Mining in 
Clinical Emergency Medicine; A Narrative Review of the Current Literature” [11]. Parva 
discusses the complexity of the body with its many systems and subsystems is much like 
the complexity and connectivity of economic and military problems that already use 
machine learning and statistics to effectively solve complex problems. Data mining 
would not only help with understanding the body and diagnosis problems but also reduce 
the waste of medical resources. Parva identifies the following areas of medical science as 
potential places data mining analysis can be applied [11]:  
 Identifying the complex mechanisms of different body subsystems and 
their interactions with each other 
 Identifying people who are at risk for diseases of a genetic predisposition 
or caused by environmental factors 
 Identifying disease mechanisms and their interactions with the problems 
of the body 
 Determining disease prognoses, and facilities management 
 Establishing decision support systems to make the best decision, 




involved in determining the course of the disease, in emergencies, or in 
acute phases of a disease 
 Evaluating diagnostic and treatment tasks and relationships and 
identifying shortcomings and capabilities 
 Finding the best screening methods for diseases and injuries, particularly 
for patients in critical conditions.  
The paper continues by discussing the studies that have already applied data 
mining in various medical areas including, cancer, prognosis of patients after lung 
transplantation, determining diseases and facilities management, and decision support 
system. 
 
2.3 Endoscopy and Histology 
E. Mossotto et al. studies the use of ensemble learners, linear discriminant 
analysis and support vector machine (SVM) for IBD diagnosis in their paper 
“Classification of Paediatric Inflammatory Bowel Disease using Machine Learning” [12]. 
Mossotto’s research uses data obtained from endoscopy and histology (study of the 
microscopic structure of tissues) at initial diagnosis from 287 IBD patients (178 CD, 80 
UC, and 29 unclassified IBD (IBDU)). This study has no healthy controls to provide a 
baseline for people with IBD, which means that this study only provide insight in the 
difference between types of IBD. This study investigates both unsupervised and 
supervised learning. The unsupervised clustering did not should significant separation 
between types of IBD. Hierarchical clustering is able to group most patients into 4 groups 




in order to decision which model to optimize; simple tree, medium tree, complex tree, 
linear discriminant analysis, linear SVM, quadratic SVM, cubic SVM, boosted trees, and 
bagged trees. Out of these models, linear discriminant analysis had the best accuracy with 
81.0% followed closely by linear SVM which was a half percent lower. The SVM was 
used for optimization for its adaptability and interpretability. The optimized SVM when 
looking at both the endoscopy and histology data had the best accuracy with 82.7%. 
 
2.4 Promteomic Mass Spectra 
Pierre Geurts al et. perform a study in “Proteomic mass spectra classification 
using decision tree-based ensemble methods” [13]. This study’s goal is to propose a 
flexible method to analysis and learn from proteomic mass spectra with the hopes of a 
framework that would be able to diagnosis multiple diseases. This study uses rheumatoid 
arthritis and IBD as proof of concept with the hopes of expanding to other diseases. 
Using rheumatoid arthritis and IBD have some shared characteristics and can treated with 
the same medication [14]. This demonstrates that similar problem, but different problems 
can be tackled by in a similar way. Geurts used the following models: single decision 
tree, bagging, random forests, extra-trees, boosting, k-nearest neighbors, and support 
vector machine. This paper uses a mass spectrometry data that generates protein profiles 
from body fluids with 240 instances with both IBD patients and healthy controls. Their 
experiments found that the model with the best error rate for the diagnosis of IBD was 
achieved by extra-tree with a 10.02% error rate with the best discretization. This study 
also investigates attribute importance ranking and biomarker selection. The attribute 





2.5 Metagenomic Stool Sample 
Federica Gigliucci al et. looks at metagenomic data from stool samples to identify 
patients that are positive for Shiga toxin-producing Escherichia coli (STEC) in 
“Metagenomic Characterization of the Human Intestinal Microbiota in Fecal Samples 
from STEC-Infected Patients” [15]. The study shows that the subjects’ microbiota 
underwent a significant change between subjects with and without the STEC infection 
and even identify specific bacteria that are linked to the infection. This study has samples 
from patients with diarrhea, patients after 2 weeks from the restoration of the normal 
intestinal function, healthy subject, and patients with CD. The promising results of this 
study set a precedence for analysis the metagenomic data of stool sample when 






Chapter 3. Methodology and Dataset 
 
These experiments use the Metagenomic dataset was collected and distributed by 
the Inflammatory Bowel Disease Multi'omics Database (IBDMDB) [16] as a part of the 
Integrative Human Microbiome Project (HMP2) [17]. Metagenome is the complete 
sequencing of all genetic material in an environment. In this dataset, the environments are 
the stool samples of each participant. The analysis of the metagenomic data of a stool 
sample can give an insight into the microbiota of the participant without the having an 
endoscopy, like a colonoscopy, performed. The study has 132 participants that are 
collected from three pediatric facilities (Cincinnati Children’s Hospital, Massachusetts 
General Hospital (MGH) Pediatrics, and Emory University Hospital) and two adult 
facilities (MGH and Cedars-Sinai Medical Center). Multiple samples where taken from 
the participants creating a dataset has 1338 instances with 599 CD diagnoses, 375 UC 
diagnoses, and 364 nonIBD diagnoses as the control group of the study. The dataset has 
1453 attributes with one class attribute after preprocessing. The dataset comes in two 
part: metadata and metagenomic data.  
Table 1: HMP2: Metagenomes Dataset 




of Classes Class Distribution 
HMP2: Metagenomes 1338 1454 3 
CD – 599 
UC – 375 
nonIBD – 364 
 
The metagenomic data in the dataset is sequences of bacteria, viruses, and other 
microbes found in a participants’ stool sample while ignoring any of the human RNA for 




files that records the concentrations of the bacteria, viruses, and other microbes both as 
specific species and larger classifications [16]. These concentrations values are broken by 
according to the taxonomy of the microbes by not only looking at the concentration of 
specific species but also kingdom, phylum, class, order, family, genus, and trinomen 
(subspecies). There were about 540 different species identified but with filtering out of 
any species with less than 0.01% abundance, they narrowed the study do to 109 species 
[16]. 
The metadata contents attributes that were collected by having each participant 
fill out a form asking questions about their health, recent diet, and general information 
about themselves (age, sex, race, etc.). Some of these attributes were removed from the 
dataset during preprocessing because they had the same value for every data point and/or 
they were included for clerical purposes only and do not have any effect on the diagnosis 
(ex: Name of the testing center). The attribute “Age at diagnosis” was also remove 
because only the participants that have IBD have a diagnosis age. To allow for the both 
the binary and ternary classifications, the diagnosis attributes must make a new dataset 
where the diagnosis attributes was processed where any CD and UC labels to IBD, when 
looking at IBD and non IBD. Two other datasets were created by removing rows for 
either CD or UC, so comparisons between CD and nonIBD and between UC and 
nonIBD. 
The models that this paper focuses on is C4.5 decision tree, RIPPER, Decision 
Table, Naïve Bayes, and k-nearest neighbor built-in models in WEKA. The ensemble 




Each model is ran with the default parameters in WEKA including using 10-fold cross-
validation for their validation unless otherwise specified.   
The C4.5 decision tree (or J48 in WEKA) creates a binary tree that can also 
ignore missing values [18]. It selected for this study because of its use in the simple 
studies, its simplicity, and readability.  The RIPPER algorithm (or JRip in WEKA) and 
Decision Table were selected for their readability and to determine the effectiveness of 
rule-based classifiers on this diagnosis problem. The JRip classifier or sometimes IREP 
using reduced error pruning along with divide and conquer method of creating greedy 
rule set one rule at a time [19]. The Decision table or sometimes Decision table majority 
(DTM) is created by finding the optimal set of features that provide the highest accuracy 
[20]. Naïve Bayes was selected because it is known for being applied to medical 
diagnosis problems [21]. Naïve Bayes classifier provide a simple approach to calculating 
probabilities by counting the frequency and combinations of values with the assumption 
that the attributes are independent of the given class [18].  K-nearest neighbor (or IBk in 
WEKA) was selected for its simplicity allows for easy implementation and explanation to 
those who have not used the model before. When classifying new data points, k-nearest 
neighbor determines what the closer existing data points (or neighbors) are and determine 
the new point class based on the classes of its neighbors [22].  
The Bagging and Boosting ensemble learning models were picked because they 
are two of the most common ensemble methods used and to draw comparison with the 
related studies which also used bagging and boosting. Bagging (also known as bootstrap 
aggregating) generates multiple versions of the selected method using bootstrap replicates 




“boost” the accuracy of other algorithm by running the classifier multiple times with 
various distributions over the training data and then combines the runs to make a single 
composite classifier [24]. 
The decision tree and RIPPER are especially focused on due to their better 
readability which allows for additional information beyond their statistics (accuracy, 
ROC, etc.). The models can also be evaluated by investing if the models created make 
logical sense with the attributes used. Also, it allows users that might not be as familiar 
with data models, such as medical professions, to understand the model while using it for 
diagnosis. Other models such as neural networks were considered for this paper but since 
the dataset has discrete and non-discrete attributes, models like neural networks are not 
suited for this type of dataset. 
All of the models were tested on five subsets of the attributes: all, metagenomic, 
meta, race, and sex. These subsets help to determine the importance of varies attributes in 
the different classification problems and in the varies models used. The attribute race was 
selected because it is known risk factor. However, sex was selected because females are 
more likely to have CD even if the sex patient is not a specific risk factor [4]. The subset 
all consists of all the attribute not remove with preprocessing, metagenomic consists only 
of the numeric concentrations values from the metagenomic data and the diagnosis, 
metadata consists of all attributes from  the metadata, race consists of the metagenomic 
values, the diagnosis, and race, and sex consists of the metagenomic values, the 
diagnosis, and sex. The metadata subset is unlikely to provide a good diagnostic tool, but 
it may lead to a better understanding of what attributes from the metadata are important 




Chapter 4. Binary Classification: IBD and nonIBD 
 
This section discusses the binary classification of instances as either IBD or 
nonIBD. This binary classification focus on whether a patient has IBD, in general, so 
future tests would have to be performed to given them a more specific diagnosis. This 
section will compare accuracies against those obtained by Geurt’s study [13]. A 
comparison is not been made to Mossotto’s study because the diagnosis is only between 
CD and UC without healthy controls [12]. 
 
4.1 Initial Results 
 Figure 1 shows a comparison between the different models on the different 
subsets on the IBD/nonIBD dataset. The dataset consists of 974 instances of IBD and 364 
instances of nonIBD. 
 4.1.1 Decision Table 
  At first glance, it appears that the decision table using the all subset is the best 
model option for the IBD and nonIBD model. The decision table has good readability and 
has the best accuracy of the models and subsets, but the rules created show that it is not a 
good option for this dataset. The table created with the all use following attributes: 
“consent_age”, “Immunosuppressants (e.g. oral corticosteroids)”, “In the past 2 weeks 
have you used an oral contrast”, “General wellbeing”, “Bowel frequency during the day”, 
and "Haemophilus pittmaniae”.  Generally a smaller decision table usually means a better 
decision table, but asking for a patients age, medications they are using, their general 
wellbeing, and looking at concentration of one bacteria, the is not going to be enough 




using the metadata subset also has quite high accuracy, but it uses the same attributes as 
the all subset minus the "Haemophilus pittmaniae” attribute. The decision table has more 
reasonable attribute selection for the other subsets, however, these tables are not as 
attractive as a choice because they have lower accuracy than the models with similar 
accuracy.  
 4.1.2 K-Nearest Neighbor 
After the decision table, k-nearest neighbor has high accuracy in comparison to 
other models. The k-nearest neighbor with all the different subsets of this dataset also 
outperformed the k-nearest neighbor from Geurts’s study which has an error rate of 
20.21% (or accuracy of 79.79%) [13]. While the accuracy of the model is the highest, the 
model has low readability. While the concept of nearest neighbor is simple and easy for 
people to understand, it is hard to actually gain additional information from the model. 
This means that no addition information can be gathered from the model which in turn 
means fewer medical professionals would trust the model’s diagnosis.  
 4.1.3 Naïve Bayes 
The Naïve Bayes model does not perform very well for all the different subsets 
with the exception of the metadata subset. This model appears to not be equipped to work 
with the metagenomic abundance data because the accuracy of this model increases with 
the two subsets that include the metadata (all and metadata subsets). However, the 
specific metadata attributes of sex and race appear to have no effect on the model since 




Bayes model being popular for medical diagnosis problems, it is not a good fit for this 
specific problem. 
 4.1.4 C4.5 Decision Tree 
The C4.5 decision tree has the best accuracy when classifying IBD and nonIBD 
when looking at the sex subset. After the decision table and k-nearest neighbor models, 
C4.5 decision tree has the highest accuracy but only when using the sex subset. The C4.5 
decision tree is quite consistent across the different subsets with the exception of the 
metadata subset, since the accuracy between subset has less than a percent difference. 
The good readability of the decision tree also makes this model more trusted because the 
user knows why the model has made its prediction. The C4.5 decision using the sex 
outperforms the single tree in Geurts’s study, with a 26.67% error rate (or accuracy of 
73.3%) [13], and it also outperforms a colonoscopy by 3.75% [10]. However, the 
accuracy of the best method in Geurts’ study which is using attribute selection by 
boosting (r = 1%) outperformed the C4.5 decision tree but only by about 0.57% [13].  
 4.1.5 RIPPER 
The RIPPER algorithm also has merit for the classification between IBD and 
nonIBD. When using the all subset, the accuracy is the highest after the decision table 
and k-nearest neighbor. Since the RIPPER is a rule-based classifier, the readability is 
excellent even for individual with little to no experience with the model itself. The size of 
the RIPPER algorithm increases its attractiveness in comparison with the C4.5 decision 
tree. The RIPPER algorithm has 11 rules while the C4.5 decision tree has a size of 89 
with 45 leaves. The receiver operating characteristic area (ROC area) of the RIPPER 




Because of these factors, RIPPER algorithm is a better model for the IBD and nonIBD 
classification problem, especially with it still outperforming the colonoscopy by 3.45% 
[10].  
   
Figure 1: IBD/nonIBD Classification Accuracy Chart 
 
4.2 Ensemble Learning 
 The ensemble methods improved the accuracy of both the C4.5 decision tree and 
the RIPPER algorithm. The increase between the single models and the bagging methods 
has a similar increase for both models with the RIPPER algorithm having a larger 
increase. The decision tree has an increase of about 3.66% while the RIPPER algorithm 
of about 4.26% while using the bagging method. The boosting, however, has a larger 
impact on the RIPPER algorithm’s accuracy then the accuracy for the decision tree (with 
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outperform Geurt’s study who’s bagging tree error rate is 16.25% (or accuracy of 
83.75%) and boosting tree’s error rate is 11.46% (or accuracy of 88.54%) [13].  
   
Figure 2: IBD/nonIBD Ensemble Methods Accuracy Chart 
 
4.3 Accuracy Improvement 
 In an attempt to improve the accuracy of the RIPPER algortihm, the number of 
optimzation runs performed during the optimization stage for both the single model and 
for ensemble learning. The default number of optimzation runs in WEKA is 2. 
 4.3.1 Best Model - RIPPER 
We see little change when only a few extra runs are added to the optimization 
stage. When changed  from 2 to 3, 4, or 5, the accuracy, false positive rate, and ROC 
Area only changes by less then a percent and with the addition of one rule. However, if 
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inceased significant and false positive rate decreases significantly. Using 10 runs has a 
sightly smaller false positive rate then using 20 runs but using 20 runs has better accuracy 
then using 10 runs (by 0.23%) and has two less rules which decrease the complex of the 
rule set. For different optimization runs performed, 20 runs is the best choice for binary 
classification. Using 20 optimization runs with the RIPPER algorithm outperforms the 
accuracy of a colonoscopy by almost 5% [10]. 
Table 2: RIPPER Optimization for IBD/nonIBD Classification 
Number of 
Optimizations Runs 
Accuracy FP Rate ROC Area Number of Rules 
2 92.45% 12.1% 90.5% 11 
3 92.45% 11.9% 90.5% 12 
4 91.93% 12.3% 90.2% 12 
5 92.90% 11.4% 90.8% 12 
10 93.72% 8.4% 93.0% 12 
20 93.95% 8.5% 93.0% 10 
 
 4.3.2 Improved Ensemble Learning 
 To continue improving accuracy, the RIPPER algortihm with 20 optizimation 
runs is used with the ensemble learning methods of bagging and boosting. As show 
above, bagging improves the 2 run RIPPER algortihm by about 4.26% and boosting 
improves it by 6.05%. From the 2 run RIPPER alogrithm,  there is an increase of about 




20 run RIPPER algorithm. While the ensemble learning with the increased number of 
optizimation runs has a high accuracy, it has a smaller increase of the accuracy.  
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Chapter 5. Binary Classification: CD and nonIBD 
 
This section discusses the binary classification of instances as either CD or 
nonIBD. This binary classification focus on whether a patient has CD, so future tests 
would have to be performed to see if a patient has UC if the test comes up negative. This 
section will compare accuracies against those obtained by Geurt’s study but keep in mind 
that their study is comparing IBD and nonIBD [13]. A comparison is not been made to 
Mossotto’s study because the diagnosis is only between CD and UC without healthy 
controls [12]. 
 
5.1 Initial Results 
 Figure 4 shows a comparison between the different models on the different 
subsets on the CD/nonIBD dataset. The dataset consists of 599 instances of CD and 364 
instances of nonIBD. 
 5.1.1 Decision Table 
At first glance, it appears that the decision table using the all subset is the best 
model option for the CD and nonIBD model. The decision table has good readability and 
has the best accuracy of the models and subsets, but the rules created show that it is not a 
good option for this dataset. The table created with the all use following attributes: 
“consent_age”, “Have you ever had bowel surgery?” “General wellbeing”, and 
“Bacteroides dorei”. Generally a smaller decision table usually means a better decision 
table, but asking for a patients age, whether they have had bowel surgery, their general 
wellbeing, and looking at concentration of one bacteria, the is not going to be enough 




using the metadata subset also has quite high accuracy, but it uses the same attributes as 
the all subset minus the " Bacteroides dorei” attribute. The decision table has more 
reasonable attribute selection for the other subsets, however, these tables are not as 
attractive as a choice because they have lower accuracy than the models with similar 
accuracy.  
 5.1.2 K-Nearest Neighbor 
After the decision table, k-nearest neighbor has high accuracy in comparison to 
other models. The k-nearest neighbor with all the different subsets of this dataset also 
outperformed the k-nearest neighbor from Geurts’s study which has an error rate of 
20.21% (or accuracy of 79.79%) [13]. While the accuracy of the model is the highest, the 
model has low readability. Due to the difficulty of reading the k-nearest neighbor, no 
addition information can be gathered from the model which in turn means fewer medical 
professionals would trust the model’s diagnosis.  
5.1.3 Naïve Bayes 
The Naïve Bayes model does not perform very well for all the different subsets 
with the exception of the metadata subset. This model appears to not be equipped to work 
with the metagenomic abundance data because the accuracy of this model increases with 
the two subsets that include the metadata (all and metadata subsets). However, the 
specific metadata attributes of sex and race appear to have no effect on the model since 
the accuracy of the metagenomic, sex, and race subsets are the same. Despite the Naïve 





 5.1.4 C4.5 Decision Tree 
 The C4.5 decision tree has the best accuracy when classifying CD and nonIBD 
when looking at the all subset. After the decision table and k-nearest neighbor models, 
C4.5 decision tree has the highest accuracy but only when using the all subset.  
The C4.5 decision tree is quite consistent across the different subsets with the exception 
of the metadata subset, since the accuracy between subset has less than a percent 
difference. The good readability of the decision tree also makes this model more trusted 
because the user knows why the model has made its prediction. The C4.5 decision tree 
using the all outperforms the single tree in Geurts’s study by about 17.77% [13], and it 
also outperforms a colonoscopy by 2.07% [10]. However, the accuracy of the best 
method in Geurts’ study which is using attribute selection by boosting (r = 1%) 
outperformed the C4.5 decision tree but only by about 1.41% [13]. 
 5.1.5 RIPPER 
The RIPPER algorithm also has merit with the classification between IBD and 
nonIBD. When using the all subset, the accuracy is the highest after the decision table 
and k-nearest neighbor. Since the RIPPER is a rule-based classifier, the readability is 
excellent even for individual with little to no experience with the model itself. The size of 
the RIPPER algorithm increases its attractiveness in comparison with the C4.5 decision 
tree. The RIPPER algorithm has 11 rules while the C4.5 decision tree has a size of 85 
with 48 leaves. Because of these factors, RIPPER algorithm is a better model for the CD 
and nonIBD classification problem, especially with it still outperforming the colonoscopy 





Figure 4: CD/nonIBD Classification Accuracy 
 
5.2 Ensemble Learning 
 The ensemble methods improved the accuracy of both the C4.5 decision tree and 
the RIPPER algorithm. The boosting method performs better than bagging method. The 
C4.5 decision tree has a larger accuracy than RIPPER when using the boosting method, 
but the RIPPER algorithm performs better than C4.5 decision tree in the bagging method. 
In the bagging method, the decision tree has an increase of about 3.32% while the 
RIPPER algorithm of about 5.82%. The boosting, however, has a larger impact on the 
RIPPER algorithm’s accuracy then the accuracy for the decision tree (with about an 
7.17% and 6.65% respectively), but the C4.5 decision tree has larger accuracy then the 
RIPPER algorithm. This study’s bagging and boosting for trees outperform Geurt’s study 
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Figure 5: CD/nonIBD Ensemble Methods Accuracy 
 
5.3 Accuracy Improvement  
 In an attempt to increase the accuracy of the C4.5 decision tree, the confidence 
factor related to pruning the tree has been changed. The default value in WEKA for the 
confidence factor is 0.25. The decrease of this number increases the amount of pruning. 
In this experiment, the confidence factor will only be lowered to guard against 
overfitting. 
 5.3.1 Best Model – C4.5 Decision Tree 
 Very little change occurs in the accuracy when the confidence factor is decreased. 
The accuracy does increase between the confidence factor 0.25 and 0.20 or 0.25and 0.15. 
The decision trees with confidence factors 0.20 and 0.15 have the same accuracy with 
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Area increasing by 0.1%, the number of leaves decreasing by 7, and the size decreases by 
9. The confidence factors of 0.10 and 0.05 both have a decrease in accuracy with 0.05 
having the worse accuracy of the two trees created. The best accuracy made by the  
Table 3: C4.5 Decision Tree Optimization for CD/nonIBD Classification 
Confidence Factor Accuracy FP Rate ROC Area Number of Leaves Size 
0.25 91.07 % 10.2% 93.1% 48 85 
0.20 91.17% 10.0% 93.0% 48 85 
0.15 91.17% 9.9% 93.1% 41 76 
0.10 90.97% 10.4% 93.3% 41 76 
0.05 90.76% 10.7% 93.1% 41 76 
 
 5.3.2 “Improved” Ensemble Learning 
 In an attempt to increase the accuracy of the ensemble learning, the confidence 
factors of 0.20 and 0.15 are used on the C4.5 decision trees with boosting and bagging 
methods. Despite the increase in accuracy that is seen when using the confidence factor 
0.20 and 0.15, the ensemble methods had a decrease in accuracy in comparison to the 
default confidence factor. This is likely due to the decrease in size of the various trees 
created by when performing the bagging and boosting methods. The larger confidence 
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Chapter 6. Binary Classification: UC and nonIBD 
 
This section discusses the binary classification of instances as either UC or 
nonIBD. This binary classification focus on whether a patient has UC, so future tests 
would have to be performed to see if a patient has CD if the test comes up negative. This 
section will compare accuracies against those obtained by Geurt’s study but keep in mind 
that their study is comparing IBD and nonIBD [13]. A comparison is not been made to 
Mossotto’s study because the diagnosis is only between CD and UC without healthy 
controls [12].  
 
6.1 Initial Results 
Figure 5 shows a comparison between the different models on the different 
subsets on the UC/nonIBD dataset. The dataset consists of 374 instances of UC and 364 
instances of nonIBD. 
 6.1.1 Decision Table 
At first glance, it appears that the decision table using the all subset is the best 
model option for the CD and nonIBD model. The decision table has good readability and 
has the best accuracy of the models and subsets, but the rules created show that it is not a 
good option for this dataset. The table created with the all use following attributes: 
“Starch (white rice bread pizza potatoes yams cereals pancakes etc.) ”, “General 
wellbeing”, “Bowel frequency during the day”, “Eggerthella”, “Lactobacillus” and 
“Haemophilus pittmaniae”. Generally a smaller decision table usually means a better 
decision table, but asking for a patients age, whether they have had bowel surgery, their 




enough information to diagnosis someone with a complex disease like IBD. The decision 
table using the metadata subset also has quite high accuracy, but it uses the same 
attributes as the all subset minus the " Bacteroides dorei” attribute. The decision table has 
more reasonable attribute selection for the other subsets, however, these tables are not as 
attractive as a choice because they have lower accuracy than the models with similar 
accuracy.  
 6.1.2 K-Nearest Neighbor 
After the decision table, k-nearest neighbor has high accuracy in comparison to 
other models. The k-nearest neighbor with all the different subsets of this dataset also 
outperformed the k-nearest neighbor from Geurts’s study which has an error rate of 
20.21% (or accuracy of 79.79%) [13]. While the accuracy of the model is the highest, the 
model has low readability. Due to the difficulty of reading the k-nearest neighbor, no 
addition information can be gathered from the model which in turn means fewer medical 
professionals would trust the model’s diagnosis.  
 6.1.3 Naïve Bayes 
The Naïve Bayes model does not perform very well for all the different subsets 
with the exception of the metadata subset. This model appears to not be equipped to work 
with the metagenomic abundance data because the accuracy of this model increases with 
the two subsets that include the metadata (all and metadata subsets). However, the 
specific metadata attributes of sex and race appear to have no effect on the model since 




Bayes model being popular for medical diagnosis problems, it is not a good fit for this 
specific problem. 
 6.1.4 C4.5 Decision Tree 
 The C4.5 decision tree has the best accuracy when classifying UC and nonIBD 
when looking at the all subset. After the decision table and k-nearest neighbor models, 
C4.5 decision tree has the highest accuracy but only when using the all subset.  
The C4.5 decision tree is quite consistent across the different subsets with the exception 
of the metadata subset, since the accuracy between subset has less than a percent 
difference. The good readability of the decision tree also makes this model more trusted 
because the user knows why the model has made its prediction. The C4.5 decision tree 
using the all outperforms the single tree in Geurts’s study by about 17.74% [13], and it 
also outperforms a colonoscopy by 2.07% [10]. However, the accuracy of the best 
method in Geurts’ study which is using attribute selection by boosting (r = 1%) 
outperformed the C4.5 decision tree but only by about 2.25% [13]. 
6.1.5 RIPPER 
The RIPPER algorithm also has merit with the classification between IBD and 
nonIBD. When using the all subset, the accuracy is the highest after the decision table 
and k-nearest neighbor. Since the RIPPER is a rule-based classifier, the readability is 
excellent even for individual with little to no experience with the model itself. The size of 
the RIPPER algorithm increases its attractiveness in comparison with the C4.5 decision 
tree. The RIPPER algorithm has 9 rules while the C4.5 decision tree has a size of 42 with 
22 leaves. However, the RIPPER algorithm only outperforms the colonoscopy by about 





Figure 7: UC/nonIBD Classification Accuracy 
 
6.2 Ensemble Learning 
 The ensemble methods improved the accuracy of both the C4.5 decision tree and 
the RIPPER algorithm. The boosting method performs better than bagging method. The 
RIPPER has a larger accuracy than the C4.5 decision tree for both the boosting and 
bagging method. In the bagging method, the decision tree has an increase of about 4.74% 
while the RIPPER algorithm of about 9.07%. The boosting, however, has a larger impact 
on the RIPPER algorithm’s accuracy then the accuracy for the decision tree (with about 
9.47% and 6.90% respectively). This study’s bagging and boosting for trees outperform 
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Figure 8: UC/nonIBD Ensemble Methods Accuracy 
 
6.3 Accuracy Improvement  
 In an attempt to increase the accuracy of the C4.5 decision tree, the confidence 
factor related to pruning the tree has been changed. The default value in WEKA for the 
confidence factor is 0.25. The decrease of this number increases the amount of pruning. 
In this experiment, the confidence factor will only be lowered to guard against 
overfitting. 
 6.3.1 Best Model – C4.5 Decision Tree 
 There is no change in accuracy, false positive rate, size, or number of leaves 
between confidence factors of 0.25, 0.20, and 0.15, however, 0.20 and 0.15 have slightly 
increased ROC Area (by 0.01%). There is a decrease in accuracy by about 0.41%, a 
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when using the confidence factor 0.10. The confidence factor 0.05 provides a slightly 
better tree then using 0.15 with an increase of about 0.13% in accuracy and 0.4% in ROC 
Area and decrease in the false positive rate (by about 0.1%), the size, and number of 
leaves. 
Table 4: C4.5 Decision Tree Optimization for UC/nonIBD Classification 
Confidence Factor Accuracy FP Rate ROC Area Number of Leaves Size 
0.25 91.07 % 8.9% 91.8% 22 42 
0.20 91.07 % 8.9% 91.9% 22 42 
0.15 91.07 % 8.9% 91.9% 22 42 
0.10 90.66% 9.3% 91.4% 22 42 
0.05 90.79% 9.2% 91.8% 20 38 
 
6.3.2 “Improved” Ensemble Learning 
 The confidence factors 0.20 and 0.15 were used to attempt to increase the 
accuracy of the ensemble learning methods. There was no increase in accuracy seen by 
the boosting or bagging methods when using either 0.20 or 0.15. Boosting sees no change 
in accuracy between using confidence factor 0.25 and 0.15 but there is a decrease in 
accuracy by about 0.54%. Bagging sees a decrease in accuracy of about 0.14% when 
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Chapter 7. Ternary Classification: CD, UC, and nonIBD 
 
This section discusses the ternary classification od instances as CD, UC or 
nonIBD. While the accuracy of the prediction does decreases but a ternary classification 
allows for the model give a more specific diagnosis between the specific types for IDB. 
In this section a comparison between the study and the study performed by Mossotto and 
the study performed by Geurts. Keep in mind that both studies are dealing with binary 
classifications and that Geurts’ study is IBD vs nonIBD while the Mossotto’s study is CD 
vs UC [12] [13]. 
 
7.1 Initial Results 
Figure 6 shows a comparison between the different models on the different 
subsets on the ternary dataset. The dataset consists of 599 instances of CD, 375 instances 
of UC, and 364 instances of nonIBD. 
 7.1.1 Decision Table 
At first glance, it appears when using the all subset is the best model option for 
the ternary classification model, but just like before the rules created show that it is not a 
good option for this dataset. The table created with the all use following attributes: 
“consent_age”, “General wellbeing”, “Bowel frequency during the day”, “Bacteroides 
fluxus”, and “Bacteroides sp 4 3 47FAA”.  Generally a smaller decision table usually 
means a better decision table, but asking for a patients age, their general wellbeing, the 
frequency of bowel movements during day and looking at concentration of two bacteria, 
the is not going to be enough information to diagnosis someone with a complex disease 




it uses the following attributes: “In the past 2 weeks have you had diarrhea?”, “General 
wellbeing”, “Arthralgias”, and “Bowel frequency during the day”. These attributes are 
also not enough to diagnosis a complex disease. The decision table has more reasonable 
attribute selection for the other subsets, however, these tables are not as attractive as a 
choice because they have lower accuracy than the models with similar accuracy.  
 7.1.2 K-Nearest Neighbor 
 The k-nearest neighbor has the second highest accuracy after the decision table. 
Due to the poor readiability of the model it is hard to trust with a task such as medical 
diagnosis especially when there are other models with signicantly high accuracy that are 
easily readiable. The k-nearest neighbor from all the subsets outperformed the k-nearest 
neighbor from Geurts’s study. The all subset outperformed Geurts’ study by about 
16.77% [13]. 
 7.1.3 Naïve Bayes 
The Naïve Bayes model does not perform very well for all the different subsets 
with the exception of the metadata subset. This model appears to not be equipped to work 
with the metagenomic abundance data because the accuracy of this model increases with 
the two subsets that include the metadata (all and metadata subsets). However, the 
specific metadata attributes of sex and race appear to have no effect on the model since 




Bayes model being popular for medical diagnosis problems, it is not a good fit for this 
specific problem. 
 7.1.4 RIPPER 
 The RIPPER algorithm has the best accuracy for ternary classification when using 
the all after the decision table and k-nearest neighbor. The RIPPER algorithm continues 
to provide a small resulting model than the C4.5 decision with the RIPPER algorithm 
creating 11 rules and the C4.5 decision tree with the best accuracy (using the race subset) 
has a size of 168 with 89 leaves. The RIPPER algoritm outperformed the optimizied 
SVM from Mossotto’s study be about 7.7% [12] and also outperformed colonoscopy’s 
accurracy by about 3.6% [10]. However, the accuracy of the best method in Geurts’ study 
which is using attribute selection by boosting (r = 1%) outperformed the C4.5 decision 
tree but only by about 0.72% [13]. 
 7.1.5 C4.5 Decision Tree 
While the C4.5 decision tree is not the best option for the ternary classification 
problem, it still has significant merit. The accuracy of the decision tree surpasses the 
RIPPER algorithm when using the metagenomic, race, and sex subsets with the best 
accuracy using the race subset. The readability of the C4.5 decision tree still makes it an 
attractive model for a diagnosis problem; however, the larger size and the lower accuracy 
means it is still not a good as a choose as the RIPPER algorithm. The RIPPER algorithm 
is still the better of the two models but the C4.5 decision tree is still an attractive model 
that should still be investigated further, especially because of itself result when looking at 
the CD/nonIBD and the UC/nonIBD classification problems. This study has better 




and the Guerts’ study by 7.15% [12].  
   
Figure 10: Ternary Classification Accuracy 
7.2 Ensemble Learning 
 The ensemble methods improved the accuracy of both the C4.5 decision tree and 
the RIPPER algorithm when using the all subset. The bagging model increases the 
accuracy of the single method with about 9.49% increase for the decision tree and about 
2.99% increase for the RIPPER algorithm. The boosting method also has a larger effect 
on the decision tree with an increase in acurracy of about 12.33%, while boosting 
increased the accuracy of the RIPPER algorithm by about 4.56%. This study’s bagging 
and boosting for trees outperform Mossotto’s study who’s bagging tree accuracy of 
77.6% and boosting tree’s accuracy of 74.8% [12] and Guert’s study who’s bagging tree 
with an error rate of 13.36% (or accuracy of 86.64%) and boosting tree’s error rate of 
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Figure 11: Ternary Ensemble Method Accuracy 
 
7.3 Accuracy Improvement 
In an attempt to improve the accuracy of the RIPPER algortihm, the number of 
optimzation runs performed during the optimization stage for both the single model and 
for ensemble learning. The default number of optimzation runs in WEKA is 2. 
 7.3.1 Best Model - RIPPER 
For ternary classification, the increase of optimization runs generally increases the 
accuracy of the rule set until too many runs are performed. The number of rules created 
also have curve that peaks around 5 runs. Running 4 and 5 runs returns the accuracy but 
when performing the 5 runs, the false positive rate increase by 0.1% and number of rules 
created increases by 2 but the ROC Area increases by 0.1%. When 20 runs are peformed, 
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in false positive rate, and a decrease in ROC Area. 
Table 4:RIPPER Optimization for Ternary Classification 
Number of 
Optimizations Runs Accuracy FP Rate ROC Area Number of Rules 
2 92.60% 4.5% 95.4% 14 
3 92.75% 4.5% 95.5% 14 
4 93.27% 4.2% 95.8% 15 
5 93.27% 4.3% 95.9% 17 
10 93.35% 4.2% 96.0% 16 
20 92.83% 4.5% 95.2% 15 
 
 7.3.2 Improved Ensemble Learning 
 To continue improving accuracy, the RIPPER algortihm with 10 optizimation 
runs is used with the ensemble learning methods of bagging and boosting. As show 
above, bagging improves the 2 runs RIPPER algortihm by about 5.83% and boosting 
improves it by 7.40%. From the 2 run RIPPER alogrithm, there is an increase of about 
2.54% when using bagging and an increase of about 4.86% when using boosting on the 
20 run RIPPER algorithm. While the ensemble learning with the increased number of 
optizimation runs has a high accuracy, it has a smaller increase of the accuracy. The 
bagging method has very little change in accuracy with only around a 0.3% change 
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Chapter 8. Discussion 
 
8.1 Change in Bacteria Abundances 
 8.1.1 Genus Coprococcus 
The root of the decision trees for all of the subset, exclude the metadata subset, 
Coprococcus eutactus for both IBD/nonIBD and ternary classification. While 
Coprococcus eutactus is not the root of the CD/nonIBD tree, it is located on the second 
level. Coprococcus eutactus is not found in the decision tree created for UC/nonIBD. The 
bacterica Coprococcus comes is found in the rules created by the RIPPER algorithm for 
the IBD/nonIBD problem. The placement of this species of bacteria makes senses given 
knowledge about its genus. Studies show that the abundance of genus Coprococcus 
decrease when a patient has IBD [25] [26]. When Coprococcus eutactus is great than 
zero percent of the total microbiota the vast majority of the instances on that side of the 
tree are diagnosis nonIBD. While the genus Coprococcus has a decrease in abundance for 
IBD patients, my research shows that it may have a more important role in CD then UC. 
Coprococcus is also found to help protect patients against colon cancer which IBD 
patients are at a higher risk of getting [27]. 
 8.1.2 Genus Alistipes 
It also appears that the bacteria genus Alistipes is important in the classification of 
IBD.  All of the rules created by the RIPPER algorithm using the genus Alistipes classify 
as nonIBD if the abundance of bacteria is higher than a specific point. Multiple bacteria 
species in this genus also appear in the varies decision trees created. This genus appears 
in at least on rule creates by the RIPPER algorithm for all four of the classification 




problem except UC/nonIBD, with it appearing relatively high in the IBD/nonIBD tree. 
This would indicate that this genus may have a stronger link the CD then to UC. This 
pattern follows because multiple studies so that multiple bacteria species from this genus 
(alistipes finegoldii, alistipes putredinis, and alistipes shahii) decrease in amount and/or 
growth rate in people with IBD in comparison to healthy controls [28] [29]. All of the 
previously mention bacteria species have been specifically seen as a part of some of 
model created. 
 8.1.3 Genus Bacteroides 
 The bacteria genus Bacteroides is the genus that is found most often seen in the 
rules created by the RIPPER algorithm and the nodes of the C4.5 decision trees across all 
four classification problems. This observation does make sense because this genus has 
been shown to have a strong link to IBD [30]. Unlike the previous bacteria genera 
discussed, there is not a set pattern seen in the rule for an increase or decrease of 
abundance for any class in particular. This may be caused by different species in the 
genus acting in different ways then each other. However, in a meta-analysis performed by 
Yingting Zhou and Fachao Zhi, it was found that different studies have shown 
contradictory results when looking at genus Bacteroides and IBD. In the FISH study and 
conventional culture studies they looked at, CD and UC patient are shown to higher 
levels of Bacteroides then healthy controls, but in the Real-Time Quantitative PCR 
studies, CD and UC patient are shown to lower levels of Bacteroides then healthy 
controls [30]. Yingting Zhou and Fachao Zhi theorized that this difference may be caused 
difference in ethnicity because the FISH study and conventional culture studies received 




were mostly Asian patients. This may explain the variety of levels seen in this study with 
a wider variety of different ethnic groups. 
 8.1.4 Specific Species 
Other bacteria that are known to decrease in abundance with patient diagnosed 
with IBD are Clostridium leptum and Faecalibacterium prausnitzi [31]. They are both 
present in the rules created by the RIPPER algorithm for ternary classification (with the 
all subset) and when the abundance is greater than or equal to a specific point then they 
are classified as nonIBD. This follows from a decrease seen in IBD patients.  However, in 
the C4.5 decision tree for ternary classification (with the all subset), Clostridium leptum 
is not present at all and the relation of Faecalibacterium prausnitzi between IBD patient 
and nonIBD is flipped. When the abundance is higher than a specific point then they are 
classified as UC and nonIBD when less than or equal to that specific point. 
 
8.2 Race and Ternary Classification 
 As previously stated, the ethnicity/race of a person can increase the chances of 
IBD [6]. However, race seems to play a bigger role when diagnosis on a ternary 
classification then IBD/nonIBD, CD/nonIBD, and UC/nonIBD classification. The best 
accuracy for the C4.5 decision tree on the ternary classification is when using the race 
subset. It increases the accuracy by about 3 percent when using the all subset and about 6 
percent when using the metagenomic subset. This increase can also be seen in the 
RIPPER algorithm. While the accuracy for RIPPER using the race subset is not larger 
than the accuracy of the all subset, there is little under a 3 percent increase in comparison 




race do not even differ by a single percent when using the C4.5 tree with metagenomic 
subset having the best accuracy. The RIPPER algorithm has more variability with the all 
subset have about 2 percent higher than either the metagenomic or race subsets. The 
metagenomic and race subsets differ less than a percent. This relation to the race attribute 
is not seen in the UC/nonIBD problem and can only be seen in the CD/nonIBD problem 
in the accuracies of the RIPPER algorithm (by about 0.83%). This leads one to believe 
that the attribute race has more importance to distinguishing between CD and UC then 
diagnosing IBD itself or diagnosing one or the other individually, with slightly more 
importance to CD diagnosis. 
 
8.3 Study Comparison 
 When using the RIPPER algorithm with the all subset consistently suppressed the 
accuracy of diagnoses from the other studies discussed in the related work. It is likely for 
two reasons. The first reason is the size of the dataset is significantly larger than in 
previous studies. The Metagenomic dataset used for this study is about 60% larger than 
the two related studies discussed earlier in this paper combined. Even the smallest 
classification (UC/nonIBD) is about 29% larger than the other two studies combined. 
With a larger dataset, the models created will be better trained models. The second reason 
is the type of data. While the protein profiles generated by the mass spectrometry, does 
provide a diagnose data for a disease, metagenomic data from a stool sample provides 
information specific to IBD and patient’s microbiota. This shifts the focus specifically on 




affects. Of the these two reason is the more significant of the two reasons is the larger 
size of the dataset. 
 This study also allows for the investigation of ternary classification of IBD. The 
previous related studies only looks at binary classification (either IBD vs nonIBD or CD 
vs UC). This study also investigates multiple binary classification problems 
(IBD/nonIBD, CD/nonIBD, and UC/nonIBD). Looking at both of these two avenues 
provides a better look into the complexity of the larger diagnosis problem. The ternary 
classification continued to outperform the accuracy of the previous studies even with the 
added complexity with the addition to a third class. The discussion of the different 
classification problems in this study is investigated further in the next section. 
 
8.4 Classification Type Comparison  
As stated before, the ternary classification, in general, is going to have lower 
accuracy then that of the binary classification counterparts. One model, however, does 
not follow this tendency, which is the RIPPER algorithm. The IBD/nonIBD accuracy is 
similar to the Ternary RIPPER algorithm with the CD/nonIBD and UC/nonIBD trailing 
behind by about 1%. This section will draw a further comparison between IBD/nonIBD 
and Ternary classification and further comparison between CD/nonIBD and UC/nonIBD.  
 8.4.1 IBD/nonIBD vs Ternary 
The RIPPER algorithm when using the all dataset has a very slight increase (by 
0.1495% with two more instances properly classified) in its accuracy between 
IBD/nonIBD and ternary classification when using the default parameters. Not only is 




measure (by 0.2%), MCC (by 7.7%), ROC area (by 4.9%), and (Precision Recall) PRC 
Area (by 0.6%) and a decrease in the false positive rate by 7.6%. This allows the ternary 
classification to be used for the RIPPER algorithm without losing accuracy but gaining 
more information for a more specific diagnosis between CD, UC, and nonIBD.  










O = 2 
92.5% 12.1% 92.4% 92.5% 92.4% 80.8% 90.5% 90.6% 
IBD/N 
O = 20 
93.9% 8.5% 94.0% 93.9% 94.0% 84.8% 93.0% 92.6% 
Ternary 
O = 2 
92.6% 4.5% 92.8% 92.6% 92.6% 88.5% 95.4% 91.2% 
Ternary 
O = 10 
93.3% 4.2% 93.5% 93.3% 93.4% 89.6% 96.0% 92.3% 
 
This increase in accuracy of the ternary classification does not continue to hold 
when the number of optimizations runs (O) is adjusted (Table 5). The binary 
classification accuracy increases and suppresses the ternary classification but only by a 
fraction of a percent. However, the ternary classification still improves upon the binary 
classification with cutting the false positive rate in half and with and increase in the MCC 
and the ROC Area. With the difference in accuracy only being less than a percentage 
point, the decrease of the false positive rate by 4.3% still makes the ternary classification 
RIPPER algorithm the superior choice. 
 This flip in accuracy does not continue for the bagging technique. The ternary 




only 2 optimization runs. When using their optimal number of optimization runs with the 
bagging method, binary classification beat ternary classification by about 1.4%. The false 
positive rates for the ternary classification continue to outperform that of the binary 
classification with the ternary improving by 4.5% when both using 2 runs and by 3% 
when using the optimal number of runs. We can also see a that MCC is higher for the 
ternary classification using bagging then binary by 1.4% when using 2 runs and by 0.3% 
when using the optimal number of runs. 











O = 2 96.7% 7.6% 96.7% 96.7% 96.7% 91.6% 99.3% 99.3% 
IBD/N 
O = 20 97.3% 5.8% 97.3% 97.3% 97.3% 93.2% 99.4% 99.2% 
Ternary 
O = 2 95.6% 3.1% 95.7% 95.6% 95.65% 93.0% 99.2% 98.9% 
Ternary 
O = 10 95.9% 2.8% 96.0% 95.9% 93.9% 93.5% 99.3% 99.0% 
 
 This flip in accuracy does not continue for the boosting technique. The ternary 
classification accuracy for boosting trailing the binary classification by 1.3% when using 
only 2 optimization runs. When using their optimal number of optimization runs with the 
boosting method, binary classification beat ternary classification by about 1.1%. The 
false positive rates for the ternary classification continue to outperform that of the binary 




the optimal number of runs, both binary and ternary classification have the same false 
positive rate.  










O = 2 
98.5% 3.1% 98.5% 98.5% 98.5% 96.2% 99.8% 99.8% 
IBD/N 
O = 20 
99.3% 1.1% 99.3% 99.3% 99.3% 98.3% 99.9% 99.9% 
Ternary 
O = 2 
97.2% 1.9% 97.2% 97.2% 97.2% 95.6% 99.6% 99.3% 
Ternary 
O = 10 
98.2% 1.1% 98.2% 98.2% 98.2% 97.2% 99.7% 99.6% 
 
Despite the binary classification methods having better accuracy when performing 
more optimization runs and when using ensemble learning methods, the ternary 
classification is still the better option. The ternary classification also for a more specific 
diagnosis and has consistently provide a lower false positive rate, except for using 
boosting on the optimal number of runs. While using the binary classification using 20 
optimization runs with boosting would provide the highest accuracy with a low false 
positive rate, it loses the ease of readability that is provided by the single model and, as 
previously said, IBD/nonIBD classification does not provide the specific diagnosis that 
ternary classification provides.   
 8.4.2 CD/nonIBD vs UC/nonIBD 
 The CD/nonIBD problem has a small increase in accuracy that UC/nonIBD does 




factor 0.25, 0.20, and 0.15 is an increase of 0.01% in the ROC Area and PRC Area with 
0.20 and 0.15. Despite the slightly better accuracy seen in the CD/nonIBD problem 
(0.1%) the UC/nonIBD consistently see a better false positive rate with a decrease of 1% 
from the best CD/nonIBD tree and a better MCC with an increase of 0.9%. There is a 
small fluctuation in the ROC Area when looking at the change between 0.25, 0.20, and 
0.15 in the CD/nonIBD. There is a drop of 0.1% between 0.25 and 0.20 and gained that 
0.1% back when using 0.15. 











91.1% 10.2% 91.1% 91.1% 91.1% 81.0% 93.1% 91.7% 
CD/N 
C=0.20 
91.2% 10.0% 91.2% 91.2% 91.2% 81.2% 93.0% 91.6% 
CD/N 
C=0.15 
91.2% 9.9% 91.2% 91.2% 91.2% 81.2% 93.1% 91.8% 
UC/N 
C=0.25 
91.1% 8.9% 91.1% 91.1% 91.1% 82.1% 91.8% 89.4% 
UC/N 
C=0.20 
91.1% 8.9% 91.1% 91.1% 91.1% 82.1% 91.9% 89.5% 
UC/N 
C=0.15 
91.1% 8.9% 91.1% 91.1% 91.1% 82.1% 91.9% 89.5% 
 
 The bagging method does not show much potential for the CD/nonIBD and 
UC/nonIBD with the smaller confidence factors. When investigating the bagging method, 
the adjusted confidence factors for both CD/nonIBD and UC/nonIBD does not provide 




increase in accuracy between the single tree and the bagging method than the 
CD/nonIBD despite its larger accuracy in the single trees. UC/nonIBD also continues to 
have a lower false positive rate than CD/nonIBD.  











94.4% 7.2% 94.4% 94.4% 94.4% 88.0% 98.7% 98.7% 
CD/N 
C=0.20 
94.3% 7.4% 94.3% 94.3% 94.3% 87.8% 98.6% 98.7% 
CD/N 
C=0.15 
93.8% 8.0% 93.8% 93.8% 93.7% 86.7% 98.6% 98.6% 
UC/N 
C=0.25 
95.8% 4.2% 95.8% 95.8% 95.8% 91.6% 98.9% 98.9% 
UC/N 
C=0.20 
95.7% 4.3% 95.7% 95.7% 95.7% 91.4% 98.9% 98.8% 
UC/N 
C=0.15 
95.4% 4.6% 95.4% 95.4% 95.4% 90.8% 98.8% 98.8% 
 
 The bagging method does not show much potential for the CD/nonIBD and 
UC/nonIBD with the smaller confidence factors. Just like the bagging method, the 
adjusted confidence factors for both CD/nonIBD and UC/nonIBD does not provide 
promising results with none of the metrics improved.  UC/nonIBD has better accuracy 
and false positive rate then CD/nonIBD just like is seen in the bagging method discussed 
before. There is a small fluctuation in the accuracy (TP Rate) when looking at the change 
between 0.25, 0.20, and 0.15 in the CD/nonIBD. There is a drop of 0.6% between 0.25 















97.7% 3.1% 97.7% 97.7% 97.7% 95.1% 99.6% 99.7%   
CD/N 
C=0.20 
96.9% 3.7% 96.9% 96.9% 96.9% 93.4% 99.4% 99.4% 
CD/N 
C=0.15 
96.7% 4.3% 96.7% 96.7% 96.7% 92.9% 99.5% 99.6% 
UC/N 
C=0.25 
98.0% 2.0% 98.0% 98.0% 98.0% 95.9% 99.8% 99.8% 
UC/N 
C=0.20 
97.4% 2.6% 97.4% 97.4% 97.4% 94.9% 99.8% 99.8% 
UC/N 
C=0.15 
98.0% 2.0% 98.0% 98.0% 98.0% 95.9% 99.8% 99.8% 
 
 Looking CD/nonIBD and UC/nonIBD using this dataset does not seem to be an 
avenue for future study for this particular dataset. While they do provide accuracies that 
are improvements to other studies, they do not complete with the ternary classification. 
The ternary classification provides a diagnosis that is more specific because it can 
determine if a patient has CD, UC, or nonIBD with a model that has higher accuracy and 
a lower false positive rate. 
 
8.5 Colonoscopy 
 The study produces many models that beat the accuracy of a colonoscopy. If one 
of these models or similar models could be incorporated or formed into medical 




Out of the current tests ordered to diagnosis, patients are most comfortable with a stool 
test. Patients have less anxiety about the pain, cost, outcome, and time of a stool test then 
a colonoscopy [9]. This would allow patients to only need to undergo a colonoscopy if it 
is truly necessary. If a diagnosis does come back as IBD positive, the patient would 
eventually need to have a colonoscopy perform, however this would allow for anyone 
without IBD to forgo the stress and expensive of a colonoscopy. The current stool test is 
also one of the test that patients are most comfortable with and is the least like to be 
refused by the patient when suggested by a medical professional [9]. This would allow 
medical professionals to have a test with higher accuracy that would be less likely refused 
by the patient and not increase the nerves of a patient without cause until more 
information can be collected. 
 
8.6 Future Work 
Future work will focus on attribute selection and importance. This would include 
making a data subset with only concentrations of bacteria genus and subset with only 
bacteria species concentrations, instead of looking at the concentrations of all the 
following: kingdom, phylum, class, order, family, genus, species, and trinomen 
(subspecies). This would determine if a bacteria genus has more or less of an impact on 
diagnosis then knowing the specific bacteria species. The only model that outperformed 
this study was using attribute selection by boosting (r = 1%) during the Geurts’ study [13] 
so attribute selection has potential to improve the accuracy.  
The investigation what attributes from the metadata are important to the diagnosis 




InfoGainAttributeEval, to help determine the importance of different data subsets and/or 
the importance of specific attributes to the problem. 
Addition future work would also investigate the varies other datasets that are 
available on the IBDMDB. These datasets include 16S, Serology, Proteomics, Viromics, 
Metabolites, Metatranscriptomes, and Host Transriptomes datasets collected by the 
HMP2. This would allow for an investigation to what types of data is more useful for the 





Chapter 9. Conclusion 
 The RIPPER algorithm is the best choice for both IBD/nonIBD and Ternary 
classification. While there is a decision tree with a larger accuracy when looking at 
IBD/nonIBD classification, the size of the tree is significantly larger than the RIPPER 
algorithm which has accuracy that is roughly the same. The C4.5 decision tree provides a 
better model for CD/nonIBD and UC/nonIBD, however their accuracy cannot compete 
with the IBD/nonIBD and Ternary classification.  The RIPPER algorithm using the 
Ternary classification with the all subset is the best models given this problem given its 
accuracy, readability, and its ability to provide a more specific diagnosis.  
 The decrease of bacteria genus Alistipes, genus Coprococcus and other bacteria 
species have been shown to increase the chance of IBD in patients. These bacteria are 
present and important in the C4.5 decision trees and the rules created by the RIPPER 
algorithm across multiple classification problems. While race/ethnicity is known to have 
an effect on a patient likelihood of having IBD, it appears to have a larger impact on the 
CD/nonIBD and Ternary classification with a more significant impact on Ternary 
classification.  
 The models presented in this study have promise in the diagnosis of IBD because 
their accuracy surpass that of the colonoscopy. It would also have the potential to provide 
a test that is less costly and less stressful for patients and less likely to be refused when 
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